Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Wang, Chuan ^a   Song, Jun ^a   Ma, Zeqiang ^b   Yang, Weifang ^c   Li, Chengqiao ^d   Zhang, Xiuping ^e   Hou, Xinguo ^a   Sun, Yu ^a   Lin, Peng ^a   Liang, Kai ^a   Gong, Lei ^a   Wang, Meijian ^a   Liu, Fuqiang ^a   Li, Wenjuan ^a   Yan, Fei ^a   Yang, Junpeng ^a   Wang, Lingshu ^a   Tian, Meng ^a   Liu, Jidong ^a   Zhao, Ruxing ^a   Chen, Li ^a   more..

^a SHANDONG UNIVERSITY   (China)

^b China National Heavy Duty Truck Group Co Ltd   (China)

^c Lukang Hospital of Jining   (China)

^d Second People's Hospital of Jining City   (China)

^e Shantui Community Health Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

2 H POSTLOAD PLASMA FASTING GLUCOSE TEST; ADULT; AGE; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FASTING GLUCOSE TEST; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GOLD STANDARD; HUMAN; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84904689803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102941     Document Type: Article

References (25)

1. Tomonaga Y, Risch L, Szucs TD, Ambuehl PM (2013) The prevalence of chronic kidney disease in a primary care setting: a Swiss cross-sectional study. PLoS One 8: e67848.
2. Zhang L, Wang F, Wang L, Wang W, Liu B, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815-822.
3. Chen YC, Su YC, Lee CC, Huang YS, Hwang SJ (2012) Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. PLoS One 7: e36332.
4. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, et al. (2012) Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308: 2349-2360.
5. Pyram R, Kansara A, Banerji MA, Loney-Hutchinson L (2012) Chronic kidney disease and diabetes. Maturitas 71: 94-103.
6. Chen W, Wang H, Dong X, Liu Q, Mao H, et al. (2009) Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 24: 1205-1212.
7. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, et al. (2011) US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 57: A8, e1-526.
8. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986.
9. Kilpatrick ES, Rigby AS, Atkin SL (2006) The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29: 1486-1490. (Pubitemid 44127568)
10. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, et al. (2013) HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care 36: 2301-2310.
11. Luk AO, Ma RC, Lau ES, Yang X, Lau WW, et al. (2013) Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 29: 384-390.
12. Ning G (2012) Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes 4: 172-173.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
15. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
16. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553. (Pubitemid 28319935)
17. American Diabetes Association (2009) Standards of medical care in diabetes-2009. Diabetes Care 32 Suppl 1: S13-61.
18. Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, et al. (2013) Glucose variability: An emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract 102: 86-95.
19. Brownlee M, Hirsch IB (2006) Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295: 1707-1708.
20. Cameron FJ, Baghurst PA, Rodbard D (2010) Assessing glycemic variation: why, when and how? Pediatr Endocrinol Rev 7 Suppl 3: 432-444.
21. Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH (2010) Glucose variability; does it matter? Endocr Rev 31: 171-182.
22. Weber C, Schnell O (2009) The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther 11: 623-633.
23. Cheng X, Gao W, Dang Y, Liu X, Li Y, et al. (2013) Both ERK/MAPK and TGF-Beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation. J Diabetes Res 2013: 463740.
24. Wang H, Wang A, Lei M, Liao J, Hu W (2013) [Effect of blood glucose fluctuation and the sustained high blood glucose on renal pathological change and collagen IV expression in diabetic rats]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 38: 818-823.
25. Jessani S, Levey AS, Bux R, Inker LA, Islam M, et al. (2014) Estimation of GFR in South Asians: a study from the general population in Pakistan. Am J Kidney Dis 63: 49-58.